A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate
Clinical trial NCT04204603 · COMPLETED
Trial details
- NCT number
- NCT04204603
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2019-09-30
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.